Clinical Trial Update: Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal doxorubicin in patients with advanced or recurrent endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED